148 related articles for article (PubMed ID: 10993018)
1. [C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women].
Biasucci LM
Ital Heart J Suppl; 2000 Aug; 1(8):1066-7. PubMed ID: 10993018
[No Abstract] [Full Text] [Related]
2. [The revival of an old diagnostic marker: C-reactive protein].
Sela B
Harefuah; 2001 Jun; 140(6):541-6. PubMed ID: 11420859
[No Abstract] [Full Text] [Related]
3. CDC/AHA Workshop on Markers of Inflammation and Cardiovascular Disease: Application to Clinical and Public Health Practice: report from the clinical practice discussion group.
Smith SC; Anderson JL; Cannon RO; Fadl YY; Koenig W; Libby P; Lipshultz SE; Mensah GA; Ridker PM; Rosenson R; ;
Circulation; 2004 Dec; 110(25):e550-3. PubMed ID: 15611380
[No Abstract] [Full Text] [Related]
4. Role of hs-CRP measurements in the current cardiovascular risk assessment.
García-Moll X; Ordóñez-Llanos J
Clin Chim Acta; 2005 May; 355(1-2):215-8. PubMed ID: 15820499
[No Abstract] [Full Text] [Related]
5. C-reactive protein and coronary heart disease.
Foody JM; Gotto AM; Wenger N
N Engl J Med; 2004 Jul; 351(3):295-8; author reply 295-8. PubMed ID: 15257565
[No Abstract] [Full Text] [Related]
6. C-reactive protein in cardiovascular risk prediction. Zooming in and zooming out.
Maseri A
Ital Heart J; 2001 Mar; 2(3):155-6. PubMed ID: 11305525
[No Abstract] [Full Text] [Related]
7. Should C-reactive protein be added to metabolic syndrome and to assessment of global cardiovascular risk?
Ridker PM; Wilson PW; Grundy SM
Circulation; 2004 Jun; 109(23):2818-25. PubMed ID: 15197153
[TBL] [Abstract][Full Text] [Related]
8. [Inflammation study in unstable angina and myocardial infarction without ST segment elevation. Value of ultra-sensitive C-reactive protein].
Borrás Pallé S; Gómez Martínez E; Romero Rodrigo A; Campos Ferrer C; Molina E; Valentín Segura V
An Med Interna; 2002 Jun; 19(6):283-8. PubMed ID: 12152386
[TBL] [Abstract][Full Text] [Related]
9. [Value of systematic biological markers of inflammation for the prognosis at 12 months of patients undergoing programmed coronary angioplasty].
Donal E; Nanadoumgar H; Ragot S; Lecron JC; Mauco G; Allal J; Herpin D
Arch Mal Coeur Vaiss; 2005 Feb; 98(2):101-7. PubMed ID: 15787300
[TBL] [Abstract][Full Text] [Related]
10. C-reactive protein, cardiovascular risk, and renal disease in a remote Australian Aboriginal community.
McDonald S; Maguire G; Duarte N; Wang XL; Hoy W
Clin Sci (Lond); 2004 Feb; 106(2):121-8. PubMed ID: 12956621
[TBL] [Abstract][Full Text] [Related]
11. C-reactive protein testing comes of age. Measuring low-grade inflammation can help refine cardiovascular risk.
Harv Heart Lett; 2009 Feb; 19(6):2. PubMed ID: 19575518
[No Abstract] [Full Text] [Related]
12. Diurnal and seasonal patterns in inflammation-sensitive biomarker level.
Dominguez-Rodriguez A; Abreu-Gonzalez P
Am J Cardiol; 2009 Jan; 103(2):293. PubMed ID: 19121457
[No Abstract] [Full Text] [Related]
13. C-reactive protein, cardiovascular disease and stroke: new roles for an old biomarker.
Willcox BJ; Abbott RD; Yano K; Rodriguez BL; Willcox DC; Curb JD
Expert Rev Neurother; 2004 May; 4(3):507-18. PubMed ID: 15853546
[TBL] [Abstract][Full Text] [Related]
14. C-reactive protein in the prediction of cardiovascular and overall mortality in middle-aged men: a population-based cohort study.
Laaksonen DE; Niskanen L; Nyyssönen K; Punnonen K; Tuomainen TP; Salonen JT
Eur Heart J; 2005 Sep; 26(17):1783-9. PubMed ID: 15821003
[TBL] [Abstract][Full Text] [Related]
15. [Inflammation and C-reactive protein in cardiovascular disease].
Munk PS; Larsen AI
Tidsskr Nor Laegeforen; 2009 Jun; 129(12):1221-4. PubMed ID: 19521445
[TBL] [Abstract][Full Text] [Related]
16. Additive value of immunoassay-measured fibrinogen and high-sensitivity C-reactive protein levels for predicting incident cardiovascular events.
Mora S; Rifai N; Buring JE; Ridker PM
Circulation; 2006 Aug; 114(5):381-7. PubMed ID: 16864722
[TBL] [Abstract][Full Text] [Related]
17. [C-reactive protein: cardiovascular issues of an acute-phase protein].
Amezcua-Guerra LM; Springall del Villar R; Bojalil Parra R
Arch Cardiol Mex; 2007; 77(1):58-66. PubMed ID: 17500194
[TBL] [Abstract][Full Text] [Related]
18. Health screening packages: the place of measuring C-reactive protein.
Wong MS
Singapore Med J; 2006 Oct; 47(10):827-9. PubMed ID: 16990955
[No Abstract] [Full Text] [Related]
19. C-reactive protein in the prediction of cardiovascular events.
Brezis M
N Engl J Med; 2003 Mar; 348(11):1059-61; author reply 1059-61. PubMed ID: 12638579
[No Abstract] [Full Text] [Related]
20. C-reactive protein: structure affects function.
Verma S; Szmitko PE; Yeh ET
Circulation; 2004 Apr; 109(16):1914-7. PubMed ID: 15117860
[No Abstract] [Full Text] [Related]
[Next] [New Search]